Deutsche Bank’s Neumora Therapeutics NMRA Stock Holding History

Deutsche Bank’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174K	Buy	+102,149	New	+$194K	﹤0.01%	3324
2025 Q2	–	Sell	-67,035	Closed	-$67K	–	3687
2025 Q1	$67K	Sell	67,035 -6,068	-8%	-$10.4K	﹤0.01%	3315
2024 Q4	$775K	Buy	73,103 +24,483	+50%	+$293K	﹤0.01%	2381
2024 Q3	$642K	Buy	48,620 +11,823	+32%	+$138K	﹤0.01%	2329
2024 Q2	$362K	Buy	36,797 +28,790	+360%	+$298K	﹤0.01%	2508
2024 Q1	$110K	Hold	8,007	–	–	﹤0.01%	3127
2023 Q4	$137K	Buy	+8,007	New	+$98.3K	﹤0.01%	3075

Other funds holding NMRA

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Deutsche Bank's NMRA Position: Q2 2026 in Review

Deutsche Bank opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 102,149 shares worth $174K. The stake represents ﹤0.01% of the portfolio and ranks #3324 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in NMRA as recently as Q1 2025.

Deutsche Bank first reported a position in NMRA in Q4 2023 and has held it in 7 quarters since. The position peaked at $775K in Q4 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

Deutsche Bank held 102,149 shares of Neumora Therapeutics worth $174K as of Q2 2026.
Neumora Therapeutics was a new Deutsche Bank position in Q2 2026.
Neumora Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3324 holding.
Deutsche Bank first reported a position in Neumora Therapeutics in Q4 2023 and has held it in 7 quarters since.
Deutsche Bank's Neumora Therapeutics position peaked at $775K in Q4 2024.
113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.